Patient‐Reported Symptom and Symptom Clusters During Immune Checkpoint Inhibitor Therapy for Cancer Patients: A Cross‐Sectional Survey
ABSTRACT Background and Aims Cancer treatment management necessitates comprehensive symptom burden assessment, particularly with therapies like immune checkpoint inhibitors (ICIs), known for unique toxicities. While ICIs show promising outcomes, they also induce immune‐related adverse events (irAEs)...
שמור ב:
| Principais autores: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley
2026-01-01
|
| סדרה: | Health Science Reports |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1002/hsr2.71708 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
